(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ALYVANT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ALYVANT

ST13

US500000079255282

Class

9, 35, 41, 42, 44

Filing

79255282

Registration

6087589

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

07/01/2025

Trademark type

Word

Nice classes

9, 35, 41, 42, 44

Filing date

07/17/2018

Registration date

06/30/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/30/2020

Last transaction

07/01/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

27

Owner location

CH

Examiner

BURDECKI, ANNIE

Law office

L80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Roivant Sciences GmbH

Representatives

Allison Strickland Ricketts Fross Zelnick Lehrman & Zissu, P.C.

Technical classification

Nice Classes

Class 9Class 35Class 41Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Computer software for providinganalyzing and generating reports; computer software for data processing; software and computer programs for the capturecollectionconversionanalysiscommunicationprocessingreceivingrecordingstorage and transmission of dataimages and information; software and computer programs for the conversionanalysisprocessingstorage and transmission of artificial intelligence; computer software for database integration; computer software for creating searchable databases of information and data; software for analyzing data in the fields of public healthhealthcarenamely pharmaceutical commercializationbiomedical research and software for analyzing clinical trial data; downloadable computer software for use in management of databases featuring pharmaceutical and medical information; downloadable computer software for management of medical practices and research; downloadable computer search engine software for obtaining and providing updated scientificmedical and clinical informationfor obtaining and providing news of general interest related to disease awareness or pharmaceutical products; computer software for accessing data and information related to healthcare services and patient medical informationfor controlling and managing data and information related to healthcare services and patient medical information; downloadable computer software for measuringmonitoringprocessing and tracking healthwellness and medical information

Class 35

Advertising services related to pharmaceutical products; business management; business administration; business research and information services; market research and provision of information regarding market research; data processing services; analysis of business data; business data and statistical analysisdocumentation being compilation of statistics and professional business consultancy services regarding statistics for biomedical researchrelated to pharmaceutical commercializationhealthcare institutions and healthcare professionalsbased on artificial intelligence and machine learning; business data analysis and statistical analysis of healthcare databiomedical research and clinical trial data for business purposes to include pharmaceutical commercialization; systematization and compilation of data in computer databases; business researchmarket testing being market research and statistical analysis services for business purposes in the fields of public healthhealthcare and biomedicinepharmaceutical commercialization and productsfor clinical trials; business advisory servicesconsultancy and information; advertisingmarketing and sales promotion services for the pharmaceutical and medical products of others; providing business intelligence services in the fields of pharmaceuticalspublic health and healthcare; providing an on-line database providing business intelligence in the fields of pharmaceuticalspublic health and healthcare

Class 41

Educational servicesnamely arrangingconducting and organizing classesseminarsconferencessymposiums and training workshops in the field of healthcare and pharmaceuticals to promote the exchange of information and resources within the scientific research and medical communities to achieve advances in the fields of healthcare and pharmaceuticalsdistribution of training materials in connection therewith

Class 42

Scientific and technological servicesresearch and design in the field of software for managing healthcare data; analysis of technical data by computersbeing technical medical research in the field of healthcareprescription and related data being carried out using computers; pharmaceutical and biomedical research services; scientific research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine; providing temporary use of online non-downloadable computer software for allowing users to connect to databases containing pharmaceutical and medical information; providing temporary use of online non-downloadable computer software for management of medical practices and research in connection with or related to pharmaceutical commercialization; providing temporary use of online non-downloadable computer search engine software for obtaining and providing updated scientificmedical and clinical informationfor obtaining and providing news of general interest; providing temporary use of online non-downloadable computer software for accessing data and information related to healthcare services and patient medical informationfor controlling and managing data and information related to healthcare services and patient medical information

Class 44

Providing health and medical information to potential customers of pharmaceutical products; providing internet-based healthcare information in support of potential commercialization of pharmaceutical products for the treatment of diseasesdisorders or conditions; providing information relating to the diagnosticprophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseasesdisorders and conditions; medical servicesproviding medical services and consultation related to pharmaceutical products or disease awareness over the telephone and via the Internet through the use of personal computerssmartphonestabletsmobile and wireless devicesother telecommunication devices; pharmaceutical advice; medical and pharmaceutical consultation related to pharmaceutical products or disease awareness; medical assistance in the nature of the provision of medical informationinformation related to pharmaceutical products or disease awareness for medical professionals and potential patients from remote locations via the Internet and global computer networks through the use of a data storage and retrieval system

Publications

History of USPTO decisions and trademark events.

34 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

06/30/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/08/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/20/2020

FIMP

FINAL DISPOSITION PROCESSED

10/20/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/30/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

06/30/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/14/2020

PUBO

PUBLISHED FOR OPPOSITION

04/14/2020

GPNX

NOTIFICATION PROCESSED BY IB

04/10/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

03/25/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

03/25/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/25/2020

ALIE

ASSIGNED TO LIE

03/11/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/05/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/03/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/02/2020

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

03/02/2020

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

11/09/2019

GNFR

FINAL REFUSAL E-MAILED

11/09/2019

CNFR

FINAL REFUSAL WRITTEN

11/09/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/09/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/09/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/09/2019

RFNP

REFUSAL PROCESSED BY IB

05/18/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

05/17/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/02/2019

RFRR

REFUSAL PROCESSED BY MPU

05/02/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/10/2019

CNRT

NON-FINAL ACTION WRITTEN

04/09/2019

MAFR

APPLICATION FILING RECEIPT MAILED

04/05/2019

DOCK

ASSIGNED TO EXAMINER

04/01/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/01/2019

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

03/29/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/28/2019

Continuous trademark protection

Get notified about every new filing that threatens ALYVANT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.